Mt. Sinai scientists push for East Harlem biotech center

TRD New York /
Aug.August 27, 2013 11:07 AM

Scientists from Mount Sinai’s medical school are considering a 10,000-square-foot East Harlem site near the Upper East Side hospital for a nonprofit work space to be shared by a dozen medical startups.

The group, known as Keystone for Incubating Innovation in Life Sciences, or KiiLN, seeks to raise $3 million to build the biotech center. They building would join two other medical developments in Upper Manhattan: Harlem Biospace at 423 West 127th Street – formerly known as the Sweets Building – and the Alexandria Center for Life Science, along the East River near 30th Street.

“[East Harlem is] slightly more affordable right now, and it’s our backyard,” Nicole McKnight, a neurologist with Mount Sinai, told DNAinfo.

The group did provide the address for the biotech hub, but said the space has been empty for five years. The planned hub will house labs, lecture halls and conference rooms, DNAinfo said. [DNAinfo]Mark Maurer

 

Related Articles

arrow_forward_ios
The MTA says it has the funding to extend the Second Avenue Subway to East Harlem, and the real estate industry is thrilled. (Credit: Getty, iStock)

Developers see dollar signs in Second Avenue subway extension

East River Plaza and Blumenfeld Development Group principal David Blumenfeld (Credit: Wikipedia and Blumenfeld Development Group)

Blumenfeld Development Group lands $235M refi for East Harlem retail center

Here’s the latest project headed to rezoned East Harlem

Richman Group lands $189M for massive East Harlem project

City used fair method to evaluate tenant displacement, judge rules

Legal Aid Society sues city, claims East Harlem rezoning will price out residents

East Harlem landlord admits to endangering tenants with gut renovation

City Council approves East Harlem rezoning

arrow_forward_ios